Skip to main content

The study of a possible correlation between serum levels of interleukin 17 and clinical severity in patients with allergic rhinitis

The full text article is temporarily unavailable.

We apologise for the inconvenience. Please try again later.

Introduction:

Allergic rhinitis (AR) is one of the most common allergic diseases, which affects ∼20% of the world's population. T-helper (Th) type 2 cells produce interleukin (IL) 4 and IL-13, and mediate allergic responses, and these cytokines have been extensively studied as key players in the atopic airway diseases. However, the involvement of Th17 cells and IL-17 in AR has not been clearly examined.

Aim:

To reevaluate AR clinical severity with serum IL-17, whether IL-17 affects the disease alone or in contribution with the atopic predisposition.

Patients and Methods:

During an 18-month period, 39 individuals were divided into three groups: A, (13 control), B (13 with mild-to-moderate AR), and C (13 with severe AR). Both group B and group C patients (26) were subjected to clinical examination and allergy skin testing, and to measurement of both total serum immunoglobulin E (IgE) and IL-17 levels. Eleven patients with AR then were exposed to 6 months of cluster immunotherapy, whereas the rest of the patients were not exposed.

Results:

Revealed a significant elevation of serum IL-17 levels with an associated increase in serum IgE in the patients with AR compared with controls and revealed that the serum levels of both total serum IgE and IL-17 decreased significantly after cluster immunotherapy.

Conclusion:

These preliminary results added new data about the use of injective immunotherapy as well as reported on the use of sublingual immunotherapy.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Allergic rhinitis; IL-17 relation to immunotherapy; IgE; correlation between IL-17 and severity; immunotherapy; interleukin 17; severity of allergy

Document Type: Research Article

Affiliations: 1: From the Microbiology and Immunology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt 2: ENT Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

Publication date: 01 October 2017

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more